Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2025 Earnings Call Transcript November 10, 2025
Inovio Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-872.10167 EPS, expectations were $-0.51.
Operator: Good afternoon, ladies and gentlemen, and welcome to the Inovio Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] This call is being recorded on Monday, November 10, 2025. And I would now like to turn the conference over to Jennie Wilson. Thank...
